Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks.
Target Price
The average target price of DNA is 11 and suggests 56% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell